Patients in states that expanded Medicare were more likely to receive all guideline-concordant treatment, from 64.7% to 69.28% in expansion states versus 61.43% to 66.67% in states that did not expand ...

In this retrospective analysis, researchers studied adult patients who were diagnosed with non-metastatic breast cancer and received GLP1-RAs for at least 3 months.

The presentations at ASCO GU signal a move toward more personalized, potent, and sequence-specific treatment strategies for genitourinary malignancies.

Researchers determined AYAs with ALL trying to schedule oncology appointments face logistical burdens when accessing initial oncology care.

FDA Commissioner Dr Marty Makary and his top deputy, Dr Vinay Prasad, detailed the plan Feb. 18 in The New England Journal of Medicine. The move is the latest in a series of FDA efforts to eliminate ...

The approval was based on the AMPLIFY trial, which evaluated acalabrutinib alongside venetoclax in adults with previously untreated CLL without del(17p) or TP53 mutation.

Investigators sought to determine whether stereotactic radiation improves symptom severity and interference with daily functioning compared with whole-brain radiation with hippocampal avoidance.

In this study, researchers used the AHA’s PREVENT equation to evaluate cardiovascular disease risk in cisplatin-treated testicular cancer survivors.

The move may signal a temporary shift in health policy under the leadership of Health Secretary Robert F. Kennedy Jr.

Investigators sought to identify perceived barriers to adopting healthy lifestyle behaviors in cancer patients and survivors.

Rybrevant Faspro is a subcutaneous co-formulation of amivantamab, a bispecific EGFR-directed and MET receptor-directed antibody, and hyaluronidase.

Regulating artificial intelligence, especially its use by health insurers, is becoming a politically divisive topic, and it’s scrambling traditional partisan lines.